Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Ireland

European Research Council grant · Running

MechanoGAP Personalised Mechanobiological Models to Predict Tumour Growth and Anti-Cancer Drug Penetration

Coordinator
University of Galway, Ireland
Runs
1 January 2024 to 31 December 2028
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101116234

What the project is doing

In the project's own words, from its summary on CORDIS.

Personalised cancer medicine presents an exciting frontier in healthcare that tailors disease mitigation and intervention to an individual patient. However, existing technologies fail to leverage the physical forces that underpin stress-dependent tumour growth and the subsequent evolution of biomechanical resistance to anti-cancer drugs. Furthermore, the fundamental mechanisms governing such force-sensitivity have yet to be uncovered; this deficiency in scientific understanding of the active biomechanical behaviour of tumours and control of drug penetration has hindered the progression of anti-cancer therapy.

In this project, an advanced computational modelling framework will first be developed to uncover the mechanisms underlying stress-dependent cell and tissue growth, coupling the thermodynamics of cellular volume control with active force generation and intracellular transport. Novel experimental analysis of 3D tumour spheroid growth and single cell biomechanics will reinforce the framework to gain a new understanding of how mechanical loading can prevent tumour cell division and the role of intracellular exchange in multi-cellular growth control.

The models will then be extended to determine the role of growth-induced stress and cell compaction in restricting drug penetration, and whether this can be mitigated by promoting intracellular drug perfusion. Finally, integrated patient-derived computational and tumour organoid models will be developed for prediction of growth and emergent biomechanical resistance to anti-cancer drugs, motivating model-led mechanobiological therapy in an animal model of breast cancer.

The overarching objective of this ground-breaking project is to pioneer a personalised healthcare framework for prediction of mechanically-regulated cancer and treatment outcomes, with remarkable potential to drive a paradigm shift in patient-specific diagnosis and treatment of cancer.

Topics

Who is involved

OrganisationCityCountryRole
University of GalwayGalwayIrelandCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI